CO205 Evaluating Disease-Free Survival (DFS) As a Surrogate Endpoint (SE) for Overall Survival (OS) in Muscle-Invasive Urothelial Carcinoma (MIUC): An Analysis of Surveillance, Epidemiology, and End Results (SEER)-Medicare Data
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.2340
https://www.valueinhealthjournal.com/article/S1098-3015(23)02440-3/fulltext
Title :
CO205 Evaluating Disease-Free Survival (DFS) As a Surrogate Endpoint (SE) for Overall Survival (OS) in Muscle-Invasive Urothelial Carcinoma (MIUC): An Analysis of Surveillance, Epidemiology, and End Results (SEER)-Medicare Data
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02440-3&doi=10.1016/j.jval.2023.03.2340
First page :
Section Title :
Open access? :
No
Section Order :
11671